Cargando…
Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Avail...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby-Year Book
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320667/ https://www.ncbi.nlm.nih.gov/pubmed/32703535 http://dx.doi.org/10.1016/j.cpcardiol.2020.100648 |
_version_ | 1783551288953274368 |
---|---|
author | Ahmed, Syed Imran Khan, Shahzad |
author_facet | Ahmed, Syed Imran Khan, Shahzad |
author_sort | Ahmed, Syed Imran |
collection | PubMed |
description | The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation. |
format | Online Article Text |
id | pubmed-7320667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mosby-Year Book |
record_format | MEDLINE/PubMed |
spelling | pubmed-73206672020-06-29 Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients Ahmed, Syed Imran Khan, Shahzad Curr Probl Cardiol Article The exceptional outbreak of COVID-19 pandemic has let the scientific community to work closely and quickly learnt things in a very short period of time. This has let us recognize that thromboembolic complications are responsible for morbidity and mortality among the COVID-19 infected patients. Available data have suggested a possible multifactorial basis of these complications, and while efforts are being made to treat this infection, preventive measures with the use of systemic anticoagulation were quickly adopted to deal with this issue. Despite obvious benefits as appeared with the use of systemic anticoagulation, most of the emerged data were retrospective, hence raise questions on the possible interplay of the confounders as well as long-term benefits and safety of systemic anticoagulation. Mosby-Year Book 2020-09 2020-06-27 /pmc/articles/PMC7320667/ /pubmed/32703535 http://dx.doi.org/10.1016/j.cpcardiol.2020.100648 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ahmed, Syed Imran Khan, Shahzad Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title | Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title_full | Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title_fullStr | Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title_full_unstemmed | Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title_short | Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients |
title_sort | coagulopathy and plausible benefits of anticoagulation among covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320667/ https://www.ncbi.nlm.nih.gov/pubmed/32703535 http://dx.doi.org/10.1016/j.cpcardiol.2020.100648 |
work_keys_str_mv | AT ahmedsyedimran coagulopathyandplausiblebenefitsofanticoagulationamongcovid19patients AT khanshahzad coagulopathyandplausiblebenefitsofanticoagulationamongcovid19patients |